Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011
07-Oct-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(iii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sanofi Healthcare India Pvt Ltd
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
29-Sep-2026 | Source : BSEKindly refer the attachment.
Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015
28-Sep-2026 | Source : BSEDisclosure received by the Company on 25th September 2026 under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations 2015 from Hoechst GmbH a promoter of the Company
Corporate Actions
No Upcoming Board Meetings
Sanofi India Ltd has declared 480% dividend, ex-date: 22 Apr 26
No Splits history available
No Bonus history available
No Rights history available